T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients-Reference-Cited by-同舟云学术

T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients

Published:2019-07 Issue:1 Volume:144 Page:306-309.e2
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Alosaimi Mohammed F.,Shendi Hiba,Beano Abdallah,Stafstrom Kelsey,El Hawary Rabab,Meshaal Safa,Galal Nermeen,Pai Sung-Yun,El-Marsafy Aisha,Geha Raif S.,Chou Janet

Funder

National Institute of Allergy and Infectious Diseases

Perkin Fund

NIAID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference9 articles.

1. Inherited DOCK2 deficiency in patients with early-onset invasive infections;Dobbs;N Engl J Med,2015

2. DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription;Nishihara;Biochem Biophys Res Commun,2002

3. DOCK2 deficiency in a patient with hyper IgM phenotype;Alizadeh;J Clin Immunol,2018

4. Mitochondrial dysfunction in human leukemic stem/progenitor cells upon loss of RAC2;Capala;PLoS One,2015

5. Metabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization;McFadden;Proc Natl Acad Sci U S A,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CPT-11 mitigates autoimmune diseases by suppressing effector T cells without affecting long-term anti-tumor immunity;Cell Death Discovery;2024-05-04

2. Long COVID as a Tauopathy: Of “Brain Fog” and “Fusogen Storms”;International Journal of Molecular Sciences;2023-08-10

3. Multiple Immune Defects in Two Patients with Novel DOCK2 Mutations Result in Recurrent Multiple Infection Including Live Attenuated Virus Vaccine;Journal of Clinical Immunology;2023-03-22

4. A novel DOCK2 variant in siblings with severe combined immunodeficiency;Scandinavian Journal of Immunology;2023-01-12

5. Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients;Clinical and Experimental Immunology;2023-01-06